 |
 |
|
|
| 货号 | 结构式 | 中文名称 | 英文名称 | 标准值 | CAS号 | 分子式 | 分子量 | 规格 | 操作 |
|---|---|---|---|---|---|---|---|---|---|
| XL-TFTN31 |  |
托法替尼杂质94 | Tofacitinib Impurity 94 | 77862-24-9 | C7H10N2 | 122.17 | 查看 | ||
| XL-TFTN30 |  |
托法替尼杂质95 | Tofacitinib Impurity 95 | NA | C20H25N5 | 335.45 | 查看 | ||
| XL-TFTN29 |  |
托法替尼杂质96 | Tofacitinib Impurity 96 | 52090-68-3 | C8H10N2O | 150.18 | 查看 | ||
| XL-TFTN28 |  |
托法替尼杂质97 | Tofacitinib Impurity 97 | 1638499-35-0 | C15H17ClN2O | 276.76 | 查看 | ||
| XL-TFTN27 |  |
托法替尼杂质98 | Tofacitinib Impurity 98 | 32018-96-5 | C13H17NO | 203.28 | 查看 | ||
| XL-TFTN26 |  |
托法替尼杂质99 | Tofacitinib Impurity 99 | NA | C15H20N2O | 244.33 | 查看 | ||
| XL-TFTN25 |  |
托法替尼杂质M | Tofacitinib Impurity M | 477600-74-1 | C13H19N5 | 245.33 | 查看 | ||
| XL-TFTN24 |  |
托法替尼杂质P | Tofacitinib Impurity P | 1092578-48-7 | C16H20N6O | 312.37 | 查看 | ||
| XL-TFTN23 |  |
托法替尼杂质Q | Tofacitinib Impurity Q | 1092578-47-6;2174011-55-1(Citrate salt) | C16H20N6O | 312.37 | 查看 | ||
| XL-TFTN22 |  |
(3S,4S)-托法替尼 | Tofacitinib Impurity Q Citrate | 1092578-47-6 (free base);2174011-55-1 | C22H28N6O8 | 504.49 | 查看 | ||
| XL-TFTN21 |  |
托法替尼杂质R | Tofacitinib impurity R | [NA] | C15H21N5O | 287.36 | 查看 | ||
| XL-TFTN20 |  |
托法替尼杂质S | Tofacitinib Impurity S | [NA] | C16H21N5O3 | 331.37 | 查看 | ||
| XL-TFTN19 |  |
托法替尼杂质T | Tofacitinib Impurity T | 1675248-19-7 | C16H22N6O2 | 330.38 | 查看 | ||
| XL-TFTN18 |  |
托法替尼杂质U | Tofacitinib impurity U | [NA] | C15H21N3 | 243.35 | 查看 | ||
| XL-TFTN17 |  |
托法替尼杂质V | Tofacitinib impurity V | [NA] | C15H21N3 | 243.35 | 查看 | ||
| XL-TFTN16 |  |
托法替尼杂质W | Tofacitinib impurity W | [NA] | C15H21N3O | 259.35 | 查看 | ||
| XL-TFTN15 |  |
托法替尼杂质X | Tofacitinib Impurity X | 1252883-90-1 | C20H25N5 | 335.45 | 查看 | ||
| XL-TFTN14 |  |
托法替尼杂质Y | Tofacitinib Impurity Y | NA | C20H25N5 | 335.45 | 查看 | ||
| XL-TFTN13 |  |
托法替尼杂质Z | Tofacitinib Impurity Z | NA | C20H25N5 | 335.45 | 查看 | ||
| XL-TFTN12 |  |
托法替尼杂质21 | Tofacitinib Impurity?21 | NA | C23H26N6O3S | 466.56 | 查看 |
